Dawson James Downgrades Cytokinetics (CYTK) to Market Outperform

November 27, 2012 9:16 AM EST Send to a Friend
Get Alerts CYTK Hot Sheet
Price: $3.47 +4.20%

Rating Summary:
    6 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 25 | New: 20
Trade CYTK Now!
Join SI Premium – FREE
Dawson James downgraded Cytokinetics (NASDAQ: CYTK) from to Market Outperform with a price target of $2.00.

For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.

Shares of Cytokinetics closed at $0.67 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Add Your Comment